Myocardiocare, Inc. company information, Employees & Contact Information

MyoCardioCare is a privately owned company founded in 2009 for the purpose of completing the development of the MCC3000 technology and introducing this life-saving device to the market. Every two minutes in the U.S., someone’s heart stops beating. Despite the best efforts of medical personnel, about 80 percent of patients suffering cardiac arrest in a hospital setting do not survive. CPR, defibrillation and other treatments are either ineffective or take too long to administer. MyoCardioCare is developing an innovative heart pump which has the potential to improve these poor outcomes. The novel design of the device employs a single-use, pneumatically-powered, flexible, polymer cup that rhythmically compresses and expands the heart, restoring and maintaining circulation. This technology is able to support the patient, and provide a bridge to surgery, transplant or other forms of treatment. Early prototypes of this technology, pioneered in the early 1990s and tested at Duke University, successfully provided patient support for days and in one case, months. These prototypes required constant bedside monitoring and adjustment, but innovations made since then have overcome these limitations.